Buprenorphine And Naloxone Film
Product Images NDC 47781-355

14 FDA label images from Alvogen Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 47781-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12mg-3mg-carton (12mg 3mg Carton)

FDA Label Image

12mg-3mg-pouch (12mg 3mg Pouch)

FDA Label Image

2mg-0pt5mg-carton (2mg 0pt5mg Carton)

FDA Label Image

2mg-0pt5mg-pouch (2mg 0pt5mg Pouch)

FDA Label Image

4mg-1mg-carton (4mg 1mg Carton)

FDA Label Image

4mg-1mg-pouch (4mg 1mg Pouch)

FDA Label Image

8mg-2mg-carton (8mg 2mg Carton)

FDA Label Image

8mg-2mg-pouch (8mg 2mg Pouch)

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Figure-2 (Figure 2)

FDA Label Image

Figure 3

FDA Label Image

Figure-4 (Figure 4)

FDA Label Image

Structure-buprenorphine (Structure Buprenorphine)

FDA Label Image

Structure-naloxone (Structure Naloxone)